Skip to main content
SpringerLink
Log in

Off-label and unlicensed drug utilization in hospitalized children in Fortaleza, Brazil

  • Pharmacoepidemiology and Prescription
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Objectives

To investigate the use of drugs, the extent and pattern of unlicensed and off-label use, and the potential relationship between off-label drug use and adverse drug reactions in northeastern Brazil.

Methods

A follow-up study of drug utilization in a general ward of a pediatric reference hospital, involving patients hospitalized for more than 24 h. Prescriptions and medical records were reviewed daily from August to December 2001. Drug licensing status of all prescriptions given to these patients was determined.

Results

A total of 272 patients were admitted during the study, 265 (97.4%) of whom received one or more drugs. The median number of drugs/patient was 6 (1–18), and the most frequent diagnosis was pneumonia (29.4% of patients). The therapeutic class most prescribed was anti-infectives for systemic use (68.8% of all children). In all, 82.6% of children received at least one unlicensed or off-label drug, and 17% received both an unlicensed and an off-label drug. Dose/frequency was the most common form of off-label drug use. Off-label drug use was significantly associated with adverse drug reactions (relative risk 2.44; 95% CI 2.12, 2.89).

Conclusions

Although off-label drug use is a complex issue and is not synonymous with inappropriate drug use, a high rate of unlicensed/off-label drug use was found and was also associated with an increased risk of adverse drug reactions. More efforts are needed to increase rational drug use in children.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Gilman JT, Gal P (1992) Pharmacokinetic and pharmacodynamic data collection in children and neonates. Clin Pharmacokinet 23:1–9

    PubMed  CAS  Google Scholar 

  2. Kauffman RE, Kearns GL (1992) Pharmacokinetic studies in pediatric patients. Clin Pharmacokinet 23:10–29

    Article  PubMed  CAS  Google Scholar 

  3. Koren G, Macleod SM (1989) The state of pediatric clinical pharmacology: an international survey of training programs. Clin Pharmacol Ther 5:489–493

    Google Scholar 

  4. Sinkowitz RL, Keyserling H, Walker TJ, Holland J et al (1997) Epidemiology of vancomycin usage at a children’s hospital, 1993 through 1995. Pediatr Infect Dis J 16:485–489

    Article  PubMed  CAS  Google Scholar 

  5. Soumerai SB, Degnan DR (1990) Drug prescribing in pediatrics: challenges for quality improvement. Pediatrics 86:782–784

    PubMed  CAS  Google Scholar 

  6. Bonati M, Impicciatore P, Pandolfini C (2000) Registering clinical trials. Register of clinical trials in children must be set up. BMJ 320:1339–1340

    Article  PubMed  CAS  Google Scholar 

  7. Conroy S, Choonara I, Impicciatore P, Mohn A et al (2000) Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. BMJ 320:79–82

    Article  PubMed  CAS  Google Scholar 

  8. Santos DB, Coelho HLL (2006) Adverse drug reactions in hospitalized children in Fortaleza, Brazil. Pharmacoepidemiol Drug Saf 15:635–640

    Article  PubMed  Google Scholar 

  9. Shankar PR, Upadhyay DK, Subish P, Dubey AK et al (2006) Prescribing patterns among paediatric inpatients in a teaching hospital in western Nepal. Singapore Med J 47:261–265

    PubMed  CAS  Google Scholar 

  10. Pandolfini C, Bonati M (2005) A literature review on off-label drug use in children. Eur J Pediatr 164:552–555

    Article  PubMed  Google Scholar 

  11. Gonzalez MG, Caroca CM, Paris E (1998) Adverse drug reactions (ADRs) in hospitalized pediatric patients. A prospective study. Int J Clin Pharmacol Ther 36:530–533

    Google Scholar 

  12. Martinez-Mir I, Garcia-Lopez M, Palop V (1999) A prospective study of adverse drug reactions in hospitalized children. Br J Clin Pharmacol 47:681–688

    Article  PubMed  CAS  Google Scholar 

  13. Turner S, Nunn T, Fielding K, Choonara I (1999) Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr 88:965–968

    Article  PubMed  CAS  Google Scholar 

  14. Mitchell AA, Goldman P, Shapiro S (1979) Drug utilization and reported adverse reactions in hospitalized children. Am J Epidemiol 110:196–204

    PubMed  CAS  Google Scholar 

  15. Meiners MMMA, Bergsten-Mendes G (2001) Prescrição de medicamentos para crianças hospitalizadas: como avaliar a qualidade? Rev Assoc Med Bras 47:332–337

    Article  PubMed  CAS  Google Scholar 

  16. Carvalho PRA, Carvalho CG, Alievi PT, Martinbiancho J et al (2003) Identificação de medicamentos “não apropriados para crianças” em prescrições de unidades de tratamento intensivo pediátrica. J Pediatr 79:397–402

    Google Scholar 

  17. Desta Z, Abula T, Gebre-Yohannes A, Worku A (2002) Drug prescribing patterns for outpatients in three hospitals in north-west Ethiopia. Ethiop J Health Dev 16:183–189

    Google Scholar 

  18. Dizwani AG, Stein CCC, Todd WT (1985) Morbidity patterns and prescribing habits in Harare primary care clinics. Farm Pract 2:82–85

    Article  CAS  Google Scholar 

  19. da Cunha AJ, Amaral J, Silva MA (2003) Inappropriate antibiotic prescription to children with acute respiratory infection in Brazil. Indian Pediatr 40:7–12

    PubMed  Google Scholar 

  20. Marlière GL, Ferraz MB, dos Santos JQ (2000) Antibiotic consumption patterns and drug leftovers in 6000 Brazilian households. Adv Ther 17:32–44

    Article  PubMed  Google Scholar 

  21. Zhanf L, Mendoza R, Costa MM, Ottoni EJ et al (2005) Antibiotic use in community-based pediatric outpatients in southern region of Brazil. J Trop Pediatr 51:304–309

    Article  Google Scholar 

  22. Aseffa A, Yohannes G (1996) Antibiotic sensitivity patterns of prevalent bacterial pathogens in Gondar, Ethiopia. East Afr Med J 73:69–73

    Google Scholar 

  23. Wallerstein RD, Gondt PK, Kasper CK (1969) State wide study of chloramphenicol and aplastic anemia. JAMA 208:2045

    Article  PubMed  CAS  Google Scholar 

  24. Leka T, Abadir M (1990) Prescribing pattern of analgesic drugs in 13 rural and regional hospitals of Ethiopia. Ethiop J Health Dev 4:15–30

    Google Scholar 

  25. Bäckström M, Hägg S, Mjörndal T, Dahlqvist R (2002) Utilization pattern of metamizole in northern Sweden and risk estimates of agranulocytosis. Pharmacoepidemiol Drug Saf 11:239–45

    Article  PubMed  Google Scholar 

  26. Hedenmalm K, Spigset O (2002) Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole). Eur J Clin Pharmacol 58:265–74

    Article  PubMed  CAS  Google Scholar 

  27. International Agranulocytosis and Aplastic Anemia Study (1986) Risk of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. JAMA 256:1749–1757

    Article  Google Scholar 

  28. Mulla H, Tofeig M, Bu‘Lock F, Samani N et al (2007) Variations in captopril formulations used to treat children with heart failure: a survey in the United Kingdom. Arch Dis Child 92:409–411

    Article  PubMed  Google Scholar 

  29. Conroy S (2003) Extemporaneous (magistral) preparations of oral medicines for children in European hospitals. Acta Paediatr 92:408–410

    PubMed  CAS  Google Scholar 

  30. Nascimento-Carvalho CM, Souza-Marques HH (2004) Recommendation of the Brazilian Society of Pediatrics for antibiotic therapy in children and adolescents with community-acquired pneumonia. Rev Panam Salud Publica 15:380–387

    Article  PubMed  Google Scholar 

  31. Agência Nacional de Vigilância Sanitária, Ministério da Saúde, Brazil (2005) Bulário. http://bulario.bvs.br Accessed 2 July 2008

  32. Martin J (2007) BNF for children. BMJ, London

  33. Takemoto CK, Hodding JH, Kraus DM (2002) Pediatric dosage handbook. Lexi-Comp, Hudson, OH

  34. World Health Organization (2007) WHO model list of essential medicines for children. First List, October 2007 http://www.who.int/childmedicines/publications/EMLc%20(2).pdf. Accessed 2 July 2008

  35. Di Paolo ER, Stoetter H, Cotting J, Frey P, Gehri M, Beck-Popovic M, Tolsa JF, Fanconi S, Pannatier A (2006) Unlicensed and off-label drug use in a Swiss paediatric university hospital. Swiss Med Wkly 136:218–22

    PubMed  Google Scholar 

  36. ‘t Jong GW, Vulto AG, de Hoog M, Schimmel KJ et al (2001) A survey of the use of off-label and unlicensed drugs in a Dutch children’s hospital. Pediatrics 108:1089–1093

    Article  PubMed  CAS  Google Scholar 

  37. Craig JS, Henderson CR, Magee FA (2001) The extent of unlicensed and off-label drug use in the paediatric ward of a district general hospital in Northern Ireland. Ir Med J 94:237–240

    PubMed  CAS  Google Scholar 

  38. Pandolfini C, Impicciatore P, Provasi D, Rocchi F et al (2002) Off-label use of drugs in Italy: a prospective, observational and multicentre study. Acta Paediatr 91:339–347

    Article  PubMed  CAS  Google Scholar 

  39. Turner S, Longworth A, Nunn T, Choonara I (1998) Unlicensed and off-label drug use in paediatric wards: prospective study. BMJ 316:343–345

    PubMed  CAS  Google Scholar 

  40. Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A, Knoeppel C, Seyberth H, Pandolfini C, Raffaelli MP, Rocchi F, Bonati M, ‘t Jong G, de Hoog M, van den Anker JN (2000) Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. Br Med J 320:79–82

    Article  CAS  Google Scholar 

  41. Gavrilov V, Lifshitz M, Levy J, Gorodischer R (2000) Unlicensed and off-label medication use in a general pediatrics ambulatory hospital unit in Israel. Isr Med Assoc J 2:595–597

    PubMed  CAS  Google Scholar 

  42. Horen B, Montastruc JL, Lapeyre-Mestre M (2002) Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol 54:665–670

    Article  PubMed  Google Scholar 

  43. Impicciatore P, Mohn A, Chiarelli F, Pandolfini C, Bonati M (2002) Adverse drug reactions to off-label drugs on a paediatric ward: an Italian prospective pilot study. Paediatr Perinat Drug Ther 5:19–24

    Article  Google Scholar 

  44. Neubert A, Dormann H, Weiss J et al (2004) The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients. Drug Saf 27:1059–1067

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Epidemiology and Public Health, Multidisciplinary Institute of Health, Federal University of Bahia, Vitória da Conquista, Bahia, Brazil

    Djanilson Barbosa Santos

  2. Department of Pharmacy, Federal University of Ceara, Fortaleza, Ceara, Brazil

    Helena Lutescia Luna Coelho

  3. Laboratory for Mother and Child Health, Mario Negri Institute of Pharmacological Research, Milan, Italy

    Antonio Clavenna & Maurizio Bonati

  4. Epidemiology and Public Health, Federal University of Bahia, Rua Porto Seguro, 66, Bairro Jardim Cruzeiro, Feira de Santana, Bahia, Brazil, CEP: 44020–070

    Djanilson Barbosa Santos

Authors
  1. Djanilson Barbosa Santos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antonio Clavenna
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maurizio Bonati
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Helena Lutescia Luna Coelho
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Djanilson Barbosa Santos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Santos, D.B., Clavenna, A., Bonati, M. et al. Off-label and unlicensed drug utilization in hospitalized children in Fortaleza, Brazil. Eur J Clin Pharmacol 64, 1111–1118 (2008). https://doi.org/10.1007/s00228-008-0543-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-008-0543-1

Keywords

Search

Navigation